BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34933669)

  • 1. Appearance of claudin-5
    Krajewski D; Paul D; Ge S; Jellison E; Pachter JS
    J Neuroinflammation; 2021 Dec; 18(1):296. PubMed ID: 34933669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of claudin-5
    Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
    J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
    Paul D; Cowan AE; Ge S; Pachter JS
    Microvasc Res; 2013 Mar; 86():1-10. PubMed ID: 23261753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
    Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
    Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
    Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
    Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-12 is not required for blood-brain barrier tight junction function.
    Castro Dias M; Coisne C; Baden P; Enzmann G; Garrett L; Becker L; Hölter SM; ; Hrabě de Angelis M; Deutsch U; Engelhardt B
    Fluids Barriers CNS; 2019 Sep; 16(1):30. PubMed ID: 31511021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
    Pfeiffer F; Schäfer J; Lyck R; Makrides V; Brunner S; Schaeren-Wiemers N; Deutsch U; Engelhardt B
    Acta Neuropathol; 2011 Nov; 122(5):601-14. PubMed ID: 21983942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.
    Argaw AT; Gurfein BT; Zhang Y; Zameer A; John GR
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1977-82. PubMed ID: 19174516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
    Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E; Chanamara S; Pleasure D; Soulika AM
    J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.
    Sagar D; Lamontagne A; Foss CA; Khan ZK; Pomper MG; Jain P
    J Neuroinflammation; 2012 Oct; 9():245. PubMed ID: 23102113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
    Hannocks MJ; Zhang X; Gerwien H; Chashchina A; Burmeister M; Korpos E; Song J; Sorokin L
    Matrix Biol; 2019 Jan; 75-76():102-113. PubMed ID: 29158162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.
    Samus M; Seelige R; Schäfer K; Sorokin L; Vestweber D
    J Leukoc Biol; 2018 Oct; 104(4):787-797. PubMed ID: 29791026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.